SCHEMBL7247654

SCHEMBL7247654

O=C1CSC(c2cccc(F)c2)N1CCCN1CCN(c2ccccn2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.56
HTR7 P34969 8/20 0.51
DRD3 P35462 10/20 0.51
DRD2 P14416 9/20 0.51
HTR1A P08908 7/20 0.51
HTR2A P28223 7/20 0.51
DRD4 P21917 6/20 0.51
DRD1 P21728 4/20 0.51
ADRA2C P18825 3/20 0.51
DRD5 P21918 3/20 0.51
HRH1 P35367 3/20 0.51
CACNA1B Q00975 2/20 0.48
SIGMAR1 Q99720 4/20 0.48
LMNA P02545 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
HTR2C P28335 1/20 0.48
CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7254585 0.89 ACHE (0.59) ACHEDRD3DRD2HTR1AHTR2A
SCHEMBL7254140 0.89 ACHE (0.56) ACHEHTR7DRD3DRD2HTR1A
SCHEMBL7250409 0.81 ACHE (0.64) ACHEHTR7GFER
SCHEMBL7254858 0.81 HTR7 (0.49) HTR7DRD3DRD2HTR1AHTR2A
SCHEMBL7248930 0.81 HTR7 (0.49) HTR7DRD3DRD2HTR1AHTR2A
SCHEMBL7248928 0.81 HTR7 (0.49) HTR7DRD3DRD2HTR1AHTR2A
SCHEMBL7254856 0.81 HTR7 (0.49) HTR7DRD3DRD2HTR1AHTR2A
SCHEMBL7248250 0.79 ACHE (0.58) ACHESIGMAR1TMEM97GFER
SCHEMBL7255245 0.78 ACHE (0.71) ACHEHTR7CACNA1BGFER
SCHEMBL7250581 0.78 HTR7 (0.47) HTR7DRD3DRD2HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506751-B1 The compounds are useful in the treatment and prevention of the AIDS virus. Intermediates useful in the preparation of the final products, pharmaceutical compositions containing the final products are also taught. invention is directed to MILLENNIUM PHARMACEUTICALS, INC. 2003-01-14 US disclosed